HEPION PHARMACEUTICALS, INC. Contractual Obligation, to be Paid, Year Four
HEPION PHARMACEUTICALS, INC. (HEPA) had Contractual Obligation, to be Paid, Year Four of $209.17 thousand as of 2018-12-31, per its 10-K filed 2019-03-14.
Discontinued › Notes › Commitment and Contingencies › Contractual Obligation, Fiscal Year Maturity
us-gaap:ContractualObligationDueInFourthYear · last filed 2019-03-14
- 2018-12-31: Contractual Obligation, to be Paid, Year Four $209.17K.
- 2017-06-30: Contractual Obligation, to be Paid, Year Four $209.17K.
- 2016-06-30: Contractual Obligation, to be Paid, Year Four $16.57K.
- 2015-06-30: Contractual Obligation, to be Paid, Year Four $132.32K.
| Period end | Contractual Obligation, to be Paid, Year Four |
|---|---|
| 2018-12-31 | $209.17K 10-K · filed 2019-03-14 |
| 2017-06-30 | $209.17K 10-KT · filed 2018-03-26 |
| 2016-06-30 | $16.57K 10-K · filed 2016-09-28 |
| 2015-06-30 | $132.32K 10-K · filed 2015-09-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |